They are information about what this experience has meant to you, and what kind of support might be genuinely useful going forward
Breakthrough T1D-funded research in GLP-1 and SGLT therapies Breakthrough T1D has a long history with GLP-1 medications like Ozempic
Proteins that contained similar peptides and could not be differentiated based on MS/MS analysis alone were grouped to satisfy the principles of parsimony
Karim A, Muhammad T, Shah I, Khan J, Qaisar R
Chem Pharm Bull (Tokyo) (2005) 53:140810
The prevalence of dyslipidemia is significantly higher in diabetic patients, especially those with type 2 diabetes, than in non-diabetic individuals (18, 19)